Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding.

Mouasni S, Gonzalez V, Schmitt A, Bennana E, Guillonneau F, Mistou S, Avouac J, Ea HK, Devauchelle V, Gottenberg JE, Chiocchia G, Tourneur L.

Cell Death Dis. 2019 Feb 25;10(3):190. doi: 10.1038/s41419-019-1412-9.

2.

Focal hyperkeratosis overlying the palmar faces of interphalangeal and metacarpophalangeal joints revealing a juvenile dermatomyositis.

Abasq-Thomas C, Devauchelle V, Fraitag S, Jay N, Gourier G, Le Duc Pennec A, Brenaut E, Misery L.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):e97-e98. doi: 10.1111/jdv.14578. Epub 2017 Oct 5. No abstract available.

PMID:
28895209
3.

Multireader assessment as an alternative to reference assessment to improve the detection of radiographic progression in a large longitudinal cohort of rheumatoid arthritis (ESPOIR).

Gandjbakhch F, Granger B, Freund R, Foltz V, Jousse-Joulin S, Devauchelle V, Afshar M, Albert JD, Bailly F, Constant E, Biale L, Milin M, Couderc M, Denarie D, Fradin A, Martaille V, Pierreisnard A, Poursac N, Saraux A, Fautrel B.

RMD Open. 2017 Jan 4;3(1):e000343. doi: 10.1136/rmdopen-2016-000343. eCollection 2017.

4.

Itch and systemic sclerosis: frequency, clinical characteristics and consequences.

Théréné C, Brenaut E, Sonbol H, Pasquier E, Saraux A, Devauchelle V, Le Moigne E, Misery L, Abasq-Thomas C.

Br J Dermatol. 2017 May;176(5):1392-1393. doi: 10.1111/bjd.14998. Epub 2017 Apr 4. No abstract available.

PMID:
27548759
5.

Tocilizumab in recent polymyalgia rheumatica: how can we manage the interleukin-6 blockage?

Devauchelle V, Saraux A.

Ann Rheum Dis. 2016 Aug;75(8):e48. doi: 10.1136/annrheumdis-2016-209607. Epub 2016 Jun 6. No abstract available.

PMID:
27268939
6.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

7.

Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).

Le Dantec C, Alonso R, Fali T, Montero E, Devauchelle V, Saraux A, Pers JO, Renaudineau Y.

Immunol Res. 2013 Jul;56(2-3):341-7. doi: 10.1007/s12026-013-8423-x.

PMID:
23576060
8.

Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.

Thabet Y, Le Dantec C, Ghedira I, Devauchelle V, Cornec D, Pers JO, Renaudineau Y.

J Autoimmun. 2013 Mar;41:175-81. doi: 10.1016/j.jaut.2013.02.002. Epub 2013 Mar 7.

PMID:
23478041
9.

Role of Toll-like receptors in primary Sjögren's syndrome with a special emphasis on B-cell maturation within exocrine tissues.

Guerrier T, Le Pottier L, Devauchelle V, Pers JO, Jamin C, Youinou P.

J Autoimmun. 2012 Aug;39(1-2):69-76. doi: 10.1016/j.jaut.2012.01.016. Epub 2012 Feb 21.

PMID:
22357449
10.

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.

Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2011 Jun;70(6):968-72. doi: 10.1136/ard.2010.143743. Epub 2011 Feb 22.

PMID:
21345815
11.

B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation.

Varin MM, Guerrier T, Devauchelle V, Youinou P, Pers JO.

Bull Group Int Rech Sci Stomatol Odontol. 2011 Nov 22;50(2):165. No abstract available.

PMID:
22750714
12.

Toll-like receptor 9 drives the maturation of B lymphocytes in the salivary glands of patients with Sjögren's syndrome.

Guerrier T, Le Pottier L, Devauchelle V, Saraux A, Youinou P, Jamin C, Pers JO.

Bull Group Int Rech Sci Stomatol Odontol. 2011 Nov 22;50(2):21-2. No abstract available.

PMID:
22750702
13.

Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome.

Alonso R, Buors C, Le Dantec C, Hillion S, Pers JO, Saraux A, Montero E, Marianowski R, Loisel S, Devauchelle V, Youinou P, Renaudineau Y.

J Autoimmun. 2010 Dec;35(4):336-41. doi: 10.1016/j.jaut.2010.07.005.

PMID:
20810246
14.

Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjögren's syndrome.

Roguedas AM, Pers JO, Lemasson G, Devauchelle V, Tobón GJ, Saraux A, Misery L, Youinou P.

J Autoimmun. 2010 Nov;35(3):241-7. doi: 10.1016/j.jaut.2010.06.014. Epub 2010 Jul 22.

PMID:
20655174
15.

Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes.

Rochas C, Hillion S, Saraux A, Mageed RA, Youinou P, Jamin C, Devauchelle V.

Arthritis Rheum. 2009 May;60(5):1261-71. doi: 10.1002/art.24498.

16.

Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells.

Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P, Pers JO.

J Immunol. 2009 Mar 15;182(6):3540-7. doi: 10.4049/jimmunol.0803588.

17.

[B lymphocytes in Sjögren's syndrome].

Pers JO, Le Pottier L, Devauchelle V, Saraux A, Youinou P.

Rev Med Interne. 2008 Dec;29(12):1000-6. doi: 10.1016/j.revmed.2008.01.018. Epub 2008 Apr 10. Review. French.

PMID:
18403061
18.

B-cell depletion and repopulation in autoimmune diseases.

Pers JO, Daridon C, Bendaoud B, Devauchelle V, Berthou C, Saraux A, Youinou P.

Clin Rev Allergy Immunol. 2008 Feb;34(1):50-5. doi: 10.1007/s12016-007-8015-4. Review.

PMID:
18270858
19.

B cell-ablative therapy: where are we now?

Bordron A, Mankaï A, Bendaoud B, Saraux A, Devauchelle V, Ghedira I, Jamin C, Pers JC, Berthou C, Youinou P.

Int J Immunopathol Pharmacol. 2007 Oct-Dec;20(4):655-9.

PMID:
18179738
20.

A conspicuous role for B cells In Sjögren's syndrome.

Youinou P, Devauchelle V, Hutin P, Le Berre R, Saraux A, Pers JO.

Clin Rev Allergy Immunol. 2007 Jun;32(3):231-7. Review.

PMID:
17992590
21.

Polarization of B effector cells in Sjögren's syndrome.

Daridon C, Guerrier T, Devauchelle V, Saraux A, Pers JO, Youinou P.

Autoimmun Rev. 2007 Aug;6(7):427-31. Epub 2007 Feb 8. Review.

PMID:
17643928
22.

Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.

Hillion S, Garaud S, Devauchelle V, Bordron A, Berthou C, Youinou P, Jamin C.

Immunology. 2007 Nov;122(3):371-80. Epub 2007 Jul 3.

23.

Quality and impact of information about interventional rheumatology: a study in 119 patients undergoing fluoroscopy-guided procedures.

Guennoc X, Samjee I, Jousse-Joulin S, Devauchelle V, Roudaut A, Saraux A.

Joint Bone Spine. 2007 Jul;74(4):353-7. Epub 2007 May 15.

PMID:
17574895
24.

BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.

Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, Hutin P, Renaudineau Y, Dueymes M, Loisel S, Berthou C, Saraux A, Youinou P.

Arthritis Rheum. 2007 May;56(5):1464-77.

25.

Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.

Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, Dueymes M, Saraux A, Youinou P, Pers JO.

Arthritis Rheum. 2007 Apr;56(4):1134-44.

26.

BAFF and rheumatic autoimmune disorders: implications for disease management and therapy.

Bosello S, Pers JO, Rochas C, Devauchelle V, De Santis M, Daridon C, Saraux A, Ferraccioli GF, Youinou P.

Int J Immunopathol Pharmacol. 2007 Jan-Mar;20(1):1-8. Review.

PMID:
17346422
27.

The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome).

Le Pottier L, Devauchelle V, Pers JO, Jamin C, Youinou P.

Autoimmun Rev. 2007 Jan;6(3):149-54. Epub 2006 Oct 16.

PMID:
17289550
28.

Is B-cell the conductor of the lymphocyte orchestra in the salivary glands of patients with primary Sjögren's syndrome.

Youinou P, Daridon C, Saraux A, Devauchelle V, Pers JO.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5):491-2. No abstract available.

PMID:
17181915
29.

Rituximab in rheumatic diseases.

Saraux A, Devauchelle V, Jousse S, Youinou P.

Joint Bone Spine. 2007 Jan;74(1):4-6. Epub 2006 Nov 13. No abstract available.

PMID:
17178461
30.

Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis.

Devauchelle V, Essabbani A, De Pinieux G, Germain S, Tourneur L, Mistou S, Margottin-Goguet F, Anract P, Migaud H, Le Nen D, Lequerré T, Saraux A, Dougados M, Breban M, Fournier C, Chiocchia G.

J Immunol. 2006 Nov 1;177(9):6471-9.

31.

Central and peripheral RAG protein re-expression: underestimate mechanisms of tolerance?

Hillion S, Rochas C, Devauchelle V, Youinou P, Jamin C.

Scand J Immunol. 2006 Sep;64(3):185-9. Review.

32.

Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.

Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Guéguen P, Hanrotel C, Gilburd B, Saraux A, Shoenfeld Y, Putterman C, Youinou P.

Arthritis Rheum. 2006 Aug;54(8):2523-32.

33.

Group B streptococcal arthritis.

Binard A, Devauchelle V, Goulesque K, Jousse S, Saraux A.

Joint Bone Spine. 2006 Jul;73(4):465-8. Epub 2006 Mar 20.

PMID:
16807040
34.

Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.

Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL, Saraux A, Youinou P.

Arthritis Rheum. 2006 Jul;54(7):2280-8.

35.

Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.

Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G.

Eur Cytokine Netw. 2005 Dec;16(4):289-92.

36.

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.

Gossec L, Le Henanff A, Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E, Euller-Ziegler L, Sibilia J, Perdriger A, Alexandre C, Dougados M.

Rheumatology (Oxford). 2006 Jul;45(7):859-62. Epub 2006 Jan 25.

PMID:
16436489
37.

BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.

d'Arbonneau F, Pers JO, Devauchelle V, Pennec Y, Saraux A, Youinou P.

Arthritis Rheum. 2006 Jan;54(1):115-26.

38.

Incidence and nature of karate injuries.

Destombe C, Lejeune L, Guillodo Y, Roudaut A, Jousse S, Devauchelle V, Saraux A.

Joint Bone Spine. 2006 Mar;73(2):182-8. Epub 2005 Jul 6.

PMID:
16126426
39.

BAFF overexpression is associated with autoantibody production in autoimmune diseases.

Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C, Youinou P.

Ann N Y Acad Sci. 2005 Jun;1050:34-9.

PMID:
16014518
40.

DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets.

Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C, Anract P, Hamadouche M, Ayral X, Dougados M, Gidrol X, Fournier C, Chiocchia G.

Genes Immun. 2004 Dec;5(8):597-608.

PMID:
15496955
41.

[What place for DNA microarray in inflammatory diseases?].

Devauchelle V, Chiocchia G.

Rev Med Interne. 2004 Oct;25(10):732-9. Review. French.

PMID:
15471599
42.

Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.

Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chalès G, Le Henaff C, Thorel JB, Hoang S, Jousse S, Baron D, Le Goff P, Youinou P.

J Rheumatol. 2003 Dec;30(12):2535-9.

PMID:
14719190
43.

Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells.

Tourneur L, Mistou S, Michiels FM, Devauchelle V, Renia L, Feunteun J, Chiocchia G.

Oncogene. 2003 May 8;22(18):2795-804.

PMID:
12743602
44.

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study.

Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E, Euller-Ziegler L, Sibilia J, Perdriger A, Mezières M, Alexandre C, Dougados M.

Rheumatology (Oxford). 2002 Nov;41(11):1280-5.

PMID:
12422001
45.

Value of laboratory tests in early prediction of rheumatoid arthritis.

Saraux A, Berthelot JM, Chalès G, Le Henaff C, Mary JY, Thorel JB, Hoang S, Dueymes M, Allain J, Devauchelle V, Baron D, Le Goff P, Youinou P.

Arthritis Rheum. 2002 Apr 15;47(2):155-65.

46.

Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France).

Saraux A, Berthelot JM, Chalès G, Le HC, Thorel J, Hoang S, Martin A, Allain J, Nouy-Trolle I, Devauchelle V, Youinou P, Le GP.

Joint Bone Spine. 2002 Jan;69(1):37-42.

PMID:
11858354
47.

Is hypocomplementemia useful for diagnosing or predicting extra-articular manifestations in patients with rheumatoid arthritis?

Saraux A, Bourdon V, Devauchelle V, Le Goff P.

Joint Bone Spine. 2001 Dec;68(6):487-92.

PMID:
11808985
48.

Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later.

Saraux A, Berthelot JM, Chalès G, Le Henaff C, Thorel JB, Hoang S, Valls I, Devauchelle V, Martin A, Baron D, Pennec Y, Botton E, Mary JY, Le Goff P, Youinou P.

Arthritis Rheum. 2001 Nov;44(11):2485-91.

49.

Changes in glycosylation of immunoglobulins in primary Sjögren's syndrome.

Basset C, Dueymes M, Devauchelle V, Mimassi NG, Pennec YL, Youinou P.

Ann Med Interne (Paris). 1998 Feb;149(1):42-4.

PMID:
11490517
50.

Fc-gamma receptor reactivity in nonorgan-specific autoimmune diseases.

Durand V, Lamour A, Devauchelle V, Youinou P, Jamin C.

Clin Rev Allergy Immunol. 2000 Feb;18(1):11-26. Review. No abstract available.

PMID:
10907104

Supplemental Content

Loading ...
Support Center